Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327682566> ?p ?o ?g. }
- W4327682566 abstract "Emerging SARS-CoV-2 variants, particularly the Omicron variant and its sublineages, continually threaten the global public health. Small molecule antivirals are an effective treatment strategy to fight against the virus. However, the first-generation antivirals either show limited clinical efficacy and/or have some defects in pharmacokinetic (PK) properties. Moreover, with increased use of these drugs across the globe, they face great pressure of drug resistance. We herein present the discovery and characterization of a new generation antiviral drug candidate (SY110), which is a potent and selective inhibitor of SARS-CoV-2 main protease (Mpro). This compound displayed potent in vitro antiviral activity against not only the predominant SARS-CoV-2 Omicron sublineage BA.5, but also other highly pathogenic human coronaviruses including SARS-CoV-1 and MERS-CoV. In the Omicron-infected K18-hACE2 mouse model, oral treatment with SY110 significantly lowered the viral burdens in lung and alleviated the virus-induced pathology. Importantly, SY110 possesses favorable PK properties with high oral drug exposure and oral bioavailability, and also an outstanding safety profile. Furthermore, SY110 exhibited sensitivity to several drug-resistance Mpro mutations. Collectively, this investigation provides a promising new drug candidate against Omicron and other variants of SARS-CoV-2." @default.
- W4327682566 created "2023-03-18" @default.
- W4327682566 creator A5002397034 @default.
- W4327682566 creator A5008997943 @default.
- W4327682566 creator A5012993899 @default.
- W4327682566 creator A5013644924 @default.
- W4327682566 creator A5024298157 @default.
- W4327682566 creator A5029937389 @default.
- W4327682566 creator A5029941351 @default.
- W4327682566 creator A5036145347 @default.
- W4327682566 creator A5039620736 @default.
- W4327682566 creator A5040481654 @default.
- W4327682566 creator A5043243528 @default.
- W4327682566 creator A5043656890 @default.
- W4327682566 creator A5049352402 @default.
- W4327682566 creator A5056975904 @default.
- W4327682566 creator A5057115300 @default.
- W4327682566 creator A5057848631 @default.
- W4327682566 creator A5058481549 @default.
- W4327682566 creator A5060378469 @default.
- W4327682566 creator A5063764563 @default.
- W4327682566 creator A5064719218 @default.
- W4327682566 creator A5069425796 @default.
- W4327682566 creator A5071446370 @default.
- W4327682566 creator A5071792600 @default.
- W4327682566 creator A5079691564 @default.
- W4327682566 creator A5082155598 @default.
- W4327682566 creator A5086248839 @default.
- W4327682566 creator A5086642105 @default.
- W4327682566 creator A5089749504 @default.
- W4327682566 date "2023-03-16" @default.
- W4327682566 modified "2023-10-05" @default.
- W4327682566 title "A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants" @default.
- W4327682566 cites W2027484375 @default.
- W4327682566 cites W2102469876 @default.
- W4327682566 cites W2110808180 @default.
- W4327682566 cites W2124026197 @default.
- W4327682566 cites W2154197653 @default.
- W4327682566 cites W2163761019 @default.
- W4327682566 cites W3003217347 @default.
- W4327682566 cites W3004280078 @default.
- W4327682566 cites W3009906937 @default.
- W4327682566 cites W3011701533 @default.
- W4327682566 cites W3016636971 @default.
- W4327682566 cites W3020300207 @default.
- W4327682566 cites W3023464695 @default.
- W4327682566 cites W3032915827 @default.
- W4327682566 cites W3047359420 @default.
- W4327682566 cites W3081918364 @default.
- W4327682566 cites W3087402740 @default.
- W4327682566 cites W3097591292 @default.
- W4327682566 cites W3114652319 @default.
- W4327682566 cites W3126546961 @default.
- W4327682566 cites W3131767541 @default.
- W4327682566 cites W3136749291 @default.
- W4327682566 cites W3177759639 @default.
- W4327682566 cites W3180285023 @default.
- W4327682566 cites W3182094313 @default.
- W4327682566 cites W3184226105 @default.
- W4327682566 cites W3188746092 @default.
- W4327682566 cites W3189646261 @default.
- W4327682566 cites W3204296702 @default.
- W4327682566 cites W4200084675 @default.
- W4327682566 cites W4205183254 @default.
- W4327682566 cites W4205331651 @default.
- W4327682566 cites W4206135665 @default.
- W4327682566 cites W4206644256 @default.
- W4327682566 cites W4206997616 @default.
- W4327682566 cites W4220886953 @default.
- W4327682566 cites W4220904663 @default.
- W4327682566 cites W4220908383 @default.
- W4327682566 cites W4224928586 @default.
- W4327682566 cites W4225286967 @default.
- W4327682566 cites W4225982774 @default.
- W4327682566 cites W4226229183 @default.
- W4327682566 cites W4248872320 @default.
- W4327682566 cites W4281754639 @default.
- W4327682566 cites W4283026725 @default.
- W4327682566 cites W4283730960 @default.
- W4327682566 cites W4290694860 @default.
- W4327682566 cites W4293539399 @default.
- W4327682566 cites W4293577332 @default.
- W4327682566 cites W4300979576 @default.
- W4327682566 cites W4308001008 @default.
- W4327682566 cites W4308683905 @default.
- W4327682566 cites W4313546219 @default.
- W4327682566 cites W4315436946 @default.
- W4327682566 cites W4319873772 @default.
- W4327682566 doi "https://doi.org/10.1038/s41392-023-01392-w" @default.
- W4327682566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36928316" @default.
- W4327682566 hasPublicationYear "2023" @default.
- W4327682566 type Work @default.
- W4327682566 citedByCount "9" @default.
- W4327682566 countsByYear W43276825662023 @default.
- W4327682566 crossrefType "journal-article" @default.
- W4327682566 hasAuthorship W4327682566A5002397034 @default.
- W4327682566 hasAuthorship W4327682566A5008997943 @default.
- W4327682566 hasAuthorship W4327682566A5012993899 @default.
- W4327682566 hasAuthorship W4327682566A5013644924 @default.
- W4327682566 hasAuthorship W4327682566A5024298157 @default.